A Path Analysis of Effects of Patients' Underlying Conditions, Treatment Satisfaction, and Adherence on Quality of Life Among Korea Glaucoma Patients

PRéCIS:: This observed patient-specific features and treatment-driven conditions that were significantly associated with the impairment of health-related quality of life (HRQOL) among glaucoma patients. The results suggest that more systematic strategies should be implemented to improve an HRQOL. To...

Full description

Saved in:
Bibliographic Details
Published in:Journal of glaucoma Vol. 28; no. 9; p. 785
Main Authors: Kim, Chan Yun, Park, Ki Ho, Ahn, Jaehong, Ahn, Myung-Douk, Cha, Soon Cheol, Kim, Ho-Soong, Kim, Joon Mo, Kim, Moon Jung, Kim, Tae-Woo, Kim, Yong Yeon, Lee, Ji Woong, Park, Sang-Woo, Sohn, Yong Ho, Sung, Kyung Rim, Yoo, Chungkwon, Cha, Jin-Hye, Kim, Young-Joo, Lee, Junyoung, Choi, Jimi
Format: Journal Article
Language:English
Published: United States 01.09.2019
ISSN:1536-481X, 1536-481X
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract PRéCIS:: This observed patient-specific features and treatment-driven conditions that were significantly associated with the impairment of health-related quality of life (HRQOL) among glaucoma patients. The results suggest that more systematic strategies should be implemented to improve an HRQOL. To determine factors contributing to an HRQOL and assess total, direct and indirect, effects that may exist between the determinants using path analysis. Data were derived from previous Korea glaucoma outcomes research. A total of 847 glaucoma outpatients with ≤2 years of eye-drop use were included in the present study. Including factors and their hypothetical pathways to an HRQOL were based on the literature review and consultation with specialists. Age, sex, comorbidities, and education levels were included as underlying conditions and treatment patterns were defined by the number of daily instillations of prescribed eye-drops. Treatment satisfaction and adherence were estimated using a Treatment Satisfaction Questionnaire for Medication, which assessed side-effects, effectiveness, convenience, global satisfaction, and pill count. An HRQOL was assessed by EQ-5D and EQ-visual analogue scale (EQ-VAS). In EQ-5D analysis, male individuals showed total effects (β=0.102, P=0.0026), including both direct (β=0.076, P=0.0095) and indirect effects (β=0.0253, P=0.0020), which were mediated by treatment satisfaction in the side effects and global satisfaction categories. Higher education (β=0.197, P=0.0020) and satisfaction in the side effect (β=0.095, P=0.0076) and global satisfaction (β=0.075, P=0.0414) categories were found to have direct effects on EQ-5D. For EQ-VAS, higher education levels had significant total effects (β=0.153, P=0.0020) accounting for direct effects (β=0.131, P=0.0030) and indirect effects (β=0.0223, P=0.0531) through global satisfaction. In addition, male individuals had indirect effects (β=0.274, P=0.0165), which was indirectly mediated by satisfaction in the global satisfaction category. Comorbidity (β=-0.096, P=0.0090) and satisfaction in the effectiveness (β=0.094, P=0.0302), convenience (β=0.076, P=0.0390), and global satisfaction (β =0.144, P=0.0020) categories showed indirect effect on EQ-VAS. Higher education and better treatment satisfaction had positive effects on HRQOL both in direct and indirect ways whereas comorbidities indirectly showed negative associations with HRQOL.
AbstractList PRéCIS:: This observed patient-specific features and treatment-driven conditions that were significantly associated with the impairment of health-related quality of life (HRQOL) among glaucoma patients. The results suggest that more systematic strategies should be implemented to improve an HRQOL.PRéCIS:: This observed patient-specific features and treatment-driven conditions that were significantly associated with the impairment of health-related quality of life (HRQOL) among glaucoma patients. The results suggest that more systematic strategies should be implemented to improve an HRQOL.To determine factors contributing to an HRQOL and assess total, direct and indirect, effects that may exist between the determinants using path analysis.PURPOSETo determine factors contributing to an HRQOL and assess total, direct and indirect, effects that may exist between the determinants using path analysis.Data were derived from previous Korea glaucoma outcomes research. A total of 847 glaucoma outpatients with ≤2 years of eye-drop use were included in the present study. Including factors and their hypothetical pathways to an HRQOL were based on the literature review and consultation with specialists. Age, sex, comorbidities, and education levels were included as underlying conditions and treatment patterns were defined by the number of daily instillations of prescribed eye-drops. Treatment satisfaction and adherence were estimated using a Treatment Satisfaction Questionnaire for Medication, which assessed side-effects, effectiveness, convenience, global satisfaction, and pill count. An HRQOL was assessed by EQ-5D and EQ-visual analogue scale (EQ-VAS).MATERIALS AND METHODSData were derived from previous Korea glaucoma outcomes research. A total of 847 glaucoma outpatients with ≤2 years of eye-drop use were included in the present study. Including factors and their hypothetical pathways to an HRQOL were based on the literature review and consultation with specialists. Age, sex, comorbidities, and education levels were included as underlying conditions and treatment patterns were defined by the number of daily instillations of prescribed eye-drops. Treatment satisfaction and adherence were estimated using a Treatment Satisfaction Questionnaire for Medication, which assessed side-effects, effectiveness, convenience, global satisfaction, and pill count. An HRQOL was assessed by EQ-5D and EQ-visual analogue scale (EQ-VAS).In EQ-5D analysis, male individuals showed total effects (β=0.102, P=0.0026), including both direct (β=0.076, P=0.0095) and indirect effects (β=0.0253, P=0.0020), which were mediated by treatment satisfaction in the side effects and global satisfaction categories. Higher education (β=0.197, P=0.0020) and satisfaction in the side effect (β=0.095, P=0.0076) and global satisfaction (β=0.075, P=0.0414) categories were found to have direct effects on EQ-5D. For EQ-VAS, higher education levels had significant total effects (β=0.153, P=0.0020) accounting for direct effects (β=0.131, P=0.0030) and indirect effects (β=0.0223, P=0.0531) through global satisfaction. In addition, male individuals had indirect effects (β=0.274, P=0.0165), which was indirectly mediated by satisfaction in the global satisfaction category. Comorbidity (β=-0.096, P=0.0090) and satisfaction in the effectiveness (β=0.094, P=0.0302), convenience (β=0.076, P=0.0390), and global satisfaction (β =0.144, P=0.0020) categories showed indirect effect on EQ-VAS.RESULTSIn EQ-5D analysis, male individuals showed total effects (β=0.102, P=0.0026), including both direct (β=0.076, P=0.0095) and indirect effects (β=0.0253, P=0.0020), which were mediated by treatment satisfaction in the side effects and global satisfaction categories. Higher education (β=0.197, P=0.0020) and satisfaction in the side effect (β=0.095, P=0.0076) and global satisfaction (β=0.075, P=0.0414) categories were found to have direct effects on EQ-5D. For EQ-VAS, higher education levels had significant total effects (β=0.153, P=0.0020) accounting for direct effects (β=0.131, P=0.0030) and indirect effects (β=0.0223, P=0.0531) through global satisfaction. In addition, male individuals had indirect effects (β=0.274, P=0.0165), which was indirectly mediated by satisfaction in the global satisfaction category. Comorbidity (β=-0.096, P=0.0090) and satisfaction in the effectiveness (β=0.094, P=0.0302), convenience (β=0.076, P=0.0390), and global satisfaction (β =0.144, P=0.0020) categories showed indirect effect on EQ-VAS.Higher education and better treatment satisfaction had positive effects on HRQOL both in direct and indirect ways whereas comorbidities indirectly showed negative associations with HRQOL.CONCLUSIONHigher education and better treatment satisfaction had positive effects on HRQOL both in direct and indirect ways whereas comorbidities indirectly showed negative associations with HRQOL.
PRéCIS:: This observed patient-specific features and treatment-driven conditions that were significantly associated with the impairment of health-related quality of life (HRQOL) among glaucoma patients. The results suggest that more systematic strategies should be implemented to improve an HRQOL. To determine factors contributing to an HRQOL and assess total, direct and indirect, effects that may exist between the determinants using path analysis. Data were derived from previous Korea glaucoma outcomes research. A total of 847 glaucoma outpatients with ≤2 years of eye-drop use were included in the present study. Including factors and their hypothetical pathways to an HRQOL were based on the literature review and consultation with specialists. Age, sex, comorbidities, and education levels were included as underlying conditions and treatment patterns were defined by the number of daily instillations of prescribed eye-drops. Treatment satisfaction and adherence were estimated using a Treatment Satisfaction Questionnaire for Medication, which assessed side-effects, effectiveness, convenience, global satisfaction, and pill count. An HRQOL was assessed by EQ-5D and EQ-visual analogue scale (EQ-VAS). In EQ-5D analysis, male individuals showed total effects (β=0.102, P=0.0026), including both direct (β=0.076, P=0.0095) and indirect effects (β=0.0253, P=0.0020), which were mediated by treatment satisfaction in the side effects and global satisfaction categories. Higher education (β=0.197, P=0.0020) and satisfaction in the side effect (β=0.095, P=0.0076) and global satisfaction (β=0.075, P=0.0414) categories were found to have direct effects on EQ-5D. For EQ-VAS, higher education levels had significant total effects (β=0.153, P=0.0020) accounting for direct effects (β=0.131, P=0.0030) and indirect effects (β=0.0223, P=0.0531) through global satisfaction. In addition, male individuals had indirect effects (β=0.274, P=0.0165), which was indirectly mediated by satisfaction in the global satisfaction category. Comorbidity (β=-0.096, P=0.0090) and satisfaction in the effectiveness (β=0.094, P=0.0302), convenience (β=0.076, P=0.0390), and global satisfaction (β =0.144, P=0.0020) categories showed indirect effect on EQ-VAS. Higher education and better treatment satisfaction had positive effects on HRQOL both in direct and indirect ways whereas comorbidities indirectly showed negative associations with HRQOL.
Author Sung, Kyung Rim
Kim, Tae-Woo
Kim, Young-Joo
Park, Sang-Woo
Cha, Jin-Hye
Park, Ki Ho
Kim, Ho-Soong
Lee, Ji Woong
Kim, Chan Yun
Sohn, Yong Ho
Lee, Junyoung
Kim, Joon Mo
Ahn, Myung-Douk
Cha, Soon Cheol
Yoo, Chungkwon
Kim, Yong Yeon
Ahn, Jaehong
Kim, Moon Jung
Choi, Jimi
Author_xml – sequence: 1
  givenname: Chan Yun
  surname: Kim
  fullname: Kim, Chan Yun
  organization: Department of Ophthalmology, Institute of Vision Research, Yonsei University, College of Medicine
– sequence: 2
  givenname: Ki Ho
  surname: Park
  fullname: Park, Ki Ho
  organization: Department of Ophthalmology, Seoul National University Hospital
– sequence: 3
  givenname: Jaehong
  surname: Ahn
  fullname: Ahn, Jaehong
  organization: Ajou University, School of Medicine, Suwon
– sequence: 4
  givenname: Myung-Douk
  surname: Ahn
  fullname: Ahn, Myung-Douk
  organization: The Catholic University of Korea, Seoul St. Mary's Hospital
– sequence: 5
  givenname: Soon Cheol
  surname: Cha
  fullname: Cha, Soon Cheol
  organization: Yeungnam University Medical Center, Daegu
– sequence: 6
  givenname: Ho-Soong
  surname: Kim
  fullname: Kim, Ho-Soong
  organization: Sungmo Eye Hospital
– sequence: 7
  givenname: Joon Mo
  surname: Kim
  fullname: Kim, Joon Mo
  organization: Department of Ophthalmology, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital
– sequence: 8
  givenname: Moon Jung
  surname: Kim
  fullname: Kim, Moon Jung
  organization: Kong Eye Clinic
– sequence: 9
  givenname: Tae-Woo
  surname: Kim
  fullname: Kim, Tae-Woo
  organization: Seoul National University Bundang Hospital, Gyeonggi-do
– sequence: 10
  givenname: Yong Yeon
  surname: Kim
  fullname: Kim, Yong Yeon
  organization: Korea University Guro Hospital
– sequence: 11
  givenname: Ji Woong
  surname: Lee
  fullname: Lee, Ji Woong
  organization: Pusan National University Hospital, Busan
– sequence: 12
  givenname: Sang-Woo
  surname: Park
  fullname: Park, Sang-Woo
  organization: Chonnam National University Medical School & Hospital, Gwangju, Republic of Korea
– sequence: 13
  givenname: Yong Ho
  surname: Sohn
  fullname: Sohn, Yong Ho
  organization: Kim's Eye Hospital
– sequence: 14
  givenname: Kyung Rim
  surname: Sung
  fullname: Sung, Kyung Rim
  organization: Asan Medical Center, University of Ulsan College of Medicine
– sequence: 15
  givenname: Chungkwon
  surname: Yoo
  fullname: Yoo, Chungkwon
  organization: Korea University Anam Hospital
– sequence: 16
  givenname: Jin-Hye
  surname: Cha
  fullname: Cha, Jin-Hye
  organization: Outcomes Research/Real World Data Team, Corporate Affairs and Health & Value Division, Pfizer Pharmaceuticals Korea Ltd
– sequence: 17
  givenname: Young-Joo
  surname: Kim
  fullname: Kim, Young-Joo
  organization: Outcomes Research/Real World Data Team, Corporate Affairs and Health & Value Division, Pfizer Pharmaceuticals Korea Ltd
– sequence: 18
  givenname: Junyoung
  surname: Lee
  fullname: Lee, Junyoung
  organization: Department of Biostatistics, Korea University College of Medicine, Seoul
– sequence: 19
  givenname: Jimi
  surname: Choi
  fullname: Choi, Jimi
  organization: Department of Biostatistics, Korea University College of Medicine, Seoul
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31233453$$D View this record in MEDLINE/PubMed
BookMark eNpNkMtOwzAQRS1URB_wBwh5B4u22I7z8DKqSilUAkQrsavceEyNErvEySIfwv-SQkGdzVxpzpyRpo861llA6JKSMSUivp0_zMbkqGhA2Qnq0TCIRjyhb52j3EV97z8IYYQxeoa6LRoEPAx66CvFz7La4tTKvPHGY6fxVGvIqp_YzgzYyl_jlVVQ5o2x73jirDKVcdYP8bIEWRUtgl9b1GuZ7QdDLK3CqdpCCTYD7Cx-qWVuqmYvXRgNOC1cq3p07T6e5bLOXCH_z52jUy1zDxeHPkCru-lycj9aPM3mk3QxyriI2UiASlisFeNRxMIYIr6JMs5UomkSJEEchlHEQxJthCYUQHEaZwS0SMINCQUBNkA3v95d6T5r8NW6MD6DPJcWXO3XrDULwrkQLXp1QOtNAWq9K00hy2b990r2DWlLeF8
CitedBy_id crossref_primary_10_63375_icrs_25_007
crossref_primary_10_2147_OPTO_S411390
crossref_primary_10_1016_j_apnr_2022_151583
crossref_primary_10_1177_11206721221128673
ContentType Journal Article
DBID NPM
7X8
DOI 10.1097/IJG.0000000000001312
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1536-481X
ExternalDocumentID 31233453
Genre Journal Article
GroupedDBID ---
.-D
.Z2
0R~
2V-
53G
5GY
5VS
8L-
AAAAV
AAHPQ
AAIQE
AARTV
AASCR
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABVCZ
ABXRP
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFDTB
AFUWQ
AGINI
AHQNM
AHRYX
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BQLVK
BS7
C45
CS3
DIWNM
DU5
DUNZO
E.X
EBS
EEVPB
EJD
EX3
F2K
F2L
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
L-C
N9A
NPM
N~M
O9-
OCUKA
ODA
OJAPA
OL1
OLG
OLV
OLW
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OXXIT
P-K
P2P
R58
RIG
RLZ
S4R
S4S
TEORI
TSPGW
V2I
W3M
WOQ
WOW
X3V
X3W
YFH
ZB8
ZFV
ZZMQN
7X8
ABPXF
ABZZY
ACBKD
ADKSD
AFBFQ
AOQMC
ID FETCH-LOGICAL-c4972-9ed827fd2466257e64b6c42d8f18383755664506b9f01eed417c0ef985b0590e2
IEDL.DBID 7X8
ISICitedReferencesCount 4
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000486052200009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1536-481X
IngestDate Sun Nov 09 09:18:46 EST 2025
Wed Feb 19 02:29:58 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4972-9ed827fd2466257e64b6c42d8f18383755664506b9f01eed417c0ef985b0590e2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://cir.nii.ac.jp/crid/1871709543036438400
PMID 31233453
PQID 2246904499
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2246904499
pubmed_primary_31233453
PublicationCentury 2000
PublicationDate 2019-09-00
20190901
PublicationDateYYYYMMDD 2019-09-01
PublicationDate_xml – month: 09
  year: 2019
  text: 2019-09-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of glaucoma
PublicationTitleAlternate J Glaucoma
PublicationYear 2019
SSID ssj0020221
Score 2.2671704
Snippet PRéCIS:: This observed patient-specific features and treatment-driven conditions that were significantly associated with the impairment of health-related...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 785
Title A Path Analysis of Effects of Patients' Underlying Conditions, Treatment Satisfaction, and Adherence on Quality of Life Among Korea Glaucoma Patients
URI https://www.ncbi.nlm.nih.gov/pubmed/31233453
https://www.proquest.com/docview/2246904499
Volume 28
WOSCitedRecordID wos000486052200009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwEA_qRHzx-2N-cYLgy8raJG3aJxni5sc2Bk7Y22ibBIXRTscE_xD_Xy9tOn0RBPtQ-nJtk7skv-TufkfIBePUS7SncCBx7XCdeE4ipHQC5uF652s_kIWmu6LfD0ejaGAP3GY2rLKaE4uJWuapOSNvGuKzyOUI0K-mr46pGmW8q7aExjKpMYQyxqrFaOFFwH09tXypgcNDb1SlzkWieXffKakL7eUxU5PyN5BZLDbtzf_-5hbZsDATWqVdbJMlle2QtZ51pO-SzxYMEPtBxUkCuYaSyLh4HJRsq7NLKOoiTUwuFFznxr1tzLQBwyo-HR5_pEc0IM4ktORzmUMIeQYlR8eHeWn3RStomeJG8JCjPHQm8RxbFS8-t0ee2jfD61vHVmhwUh4J6kRKhlRoiY3GfZRQAU-ClFMZapwpcOvrI1jkvhskkXY9XI25J1JX6Sj0E5P0qug-WcnyTB0S4MaWhJ8wqihPUokiMY1ikfooRJmuk_Oqw8c4AoxbI85UPp-Nv7u8Tg5KrY2nJVXHGLXKGPfZ0R-kj8k6oiEbQHZCahrHvzolq-k79uPbWWFaeO8Pel_Cjtfb
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Path+Analysis+of+Effects+of+Patients%27+Underlying+Conditions%2C+Treatment+Satisfaction%2C+and+Adherence+on+Quality+of+Life+Among+Korea+Glaucoma+Patients&rft.jtitle=Journal+of+glaucoma&rft.au=Kim%2C+Chan+Yun&rft.au=Park%2C+Ki+Ho&rft.au=Ahn%2C+Jaehong&rft.au=Ahn%2C+Myung-Douk&rft.date=2019-09-01&rft.issn=1536-481X&rft.eissn=1536-481X&rft.volume=28&rft.issue=9&rft.spage=785&rft_id=info:doi/10.1097%2FIJG.0000000000001312&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1536-481X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1536-481X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1536-481X&client=summon